The contents of this publication do not necessarily reflect the views or policies of the USDA nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.
A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.) †
Version of Record online: 12 JUN 2006
Copyright © 2006 John Wiley & Sons, Ltd.
Volume 20, Issue 8, pages 619–633, August 2006
How to Cite
McKay, D. L. and Blumberg, J. B. (2006), A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.) . Phytother. Res., 20: 619–633. doi: 10.1002/ptr.1936
- Issue online: 25 JUL 2006
- Version of Record online: 12 JUN 2006
- Manuscript Accepted: 27 APR 2006
- Manuscript Received: 23 FEB 2006
- U.S. Department of Agriculture (USDA) Agricultural Research Service. Grant Number: 58-1950-001
- Hain Celestial Group (Boulder, CO)
- Mentha piperita;
- peppermint oil;
- herbal tea;
Peppermint (Mentha piperita L.) is one of the most widely consumed single ingredient herbal teas, or tisanes. Peppermint tea, brewed from the plant leaves, and the essential oil of peppermint are used in traditional medicines. Evidence-based research regarding the bioactivity of this herb is reviewed. The phenolic constituents of the leaves include rosmarinic acid and several flavonoids, primarily eriocitrin, luteolin and hesperidin. The main volatile components of the essential oil are menthol and menthone. In vitro, peppermint has significant antimicrobial and antiviral activities, strong antioxidant and antitumor actions, and some antiallergenic potential. Animal model studies demonstrate a relaxation effect on gastrointestinal (GI) tissue, analgesic and anesthetic effects in the central and peripheral nervous system, immunomodulating actions and chemopreventive potential. Human studies on the GI, respiratory tract and analgesic effects of peppermint oil and its constituents have been reported. Several clinical trials examining the effects of peppermint oil on irritable bowel syndrome (IBS) symptoms have been conducted. However, human studies of peppermint leaf are limited and clinical trials of peppermint tea are absent. Adverse reactions to peppermint tea have not been reported, although caution has been urged for peppermint oil therapy in patients with GI reflux, hiatal hernia or kidney stones. Copyright © 2006 John Wiley & Sons, Ltd.